Clinical Trials Logo

Clinical Trial Summary

The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to organic erectile dysfunction, such as those associated with metabolic syndrome or the treatment of prostate cancer.


Clinical Trial Description

By enrolling patients with organic erectile dysfunction adapted to enrolled criteria, this study will document for the first time the safety and efficacy of underlying penile cellular damage. The safety will be evaluated by tolerance degree. The efficacy will be evaluated validated scores and color duplex Doppler ultrasound. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03973021
Study type Interventional
Source Fuda Cancer Hospital, Guangzhou
Contact
Status Withdrawn
Phase Phase 1/Phase 2
Start date July 1, 2019
Completion date July 1, 2020

See also
  Status Clinical Trial Phase
Terminated NCT01715571 - Assessment of Penile Vibratory Stimulation Using the Viberect in Men With Mild-Moderate ED N/A